This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The award has a ceiling value of $48,644.26 and a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is a part of a larger indefinite...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a potential value of $4,128.78 and a period of performance through February 29, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and serves as a key provider of pharmaceutical products and medical supplies to DLA...
This contract is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 5 MG TABLET 60S. The potential value of the contract is $35,766.90, with a completion date of February 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp as a single award,...
This is a firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the delivery of 4565112108 - ELIQUIS 5 MG TABLET 60S. The contract has a ceiling value of $1,762.59 and an ultimate completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The order is for the supply of ELIQUIS 5 MG TABLET 60S, with a completion date of March 8, 2024 and a potential value of $13,848.89. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit organization. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a completion date of January 26, 2024 and a potential value of $3,173.45. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) awarded by DLA, with a potential value...
This is a $29,750.63 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside programs. Amerisourcebergen...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract has a ceiling value of $1,116.61 and a period of performance through April 1, 2024. It is for the delivery of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and is a for-profit...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ELIQUIS 5 MG TABLET 60S, with a ceiling value of $23,079.58 and a period of performance through March 26, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA to...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $17,692.57 order is for the supply of ELIQUIS 5 MG TABLET 60S, with a performance period through March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract...